{
  "nct_id": "NCT47665427",
  "indication": "Breast Cancer",
  "phase": "Phase 1/2",
  "sample_size": 40,
  "duration_weeks": 64,
  "dropout_rate": 0.31,
  "blinding": "double-blind",
  "control_arm": "placebo",
  "primary_endpoints": [
    "Objective response rate"
  ],
  "secondary_endpoints": [
    "Progression-free survival"
  ],
  "outcome_summary": "Statistically significant clinical benefit observed",
  "success": 1,
  "start_date": "2022-12-27",
  "completion_date": "2024-03-19"
}